SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ebola Outbreak 2014 - News, Updates and Related Investments
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: statesidereport who wrote (67)8/4/2014 1:12:05 PM
From: statesidereport   of 608
 
Dr. Kent Brantly, American With Ebola, Got Second Dose of Serum
Dr. Kent Brantly, one of the Americans infected with Ebola in Africa, got a second dose of experimental serum after he was flown to the United States, NBC News learned. He was described as clinically stable Monday, with a lower fever and improvement in other symptoms.

Samaritan’s Purse, an aid organization that Brantly works with, had previously said that he received a first dose of the serum before he was flown out of Liberia. Doctors have not released details about the serum.

IN-DEPTH Second American Ebola Patient to Arrive in U.S. on Tuesday American Ebola Patient Dr. Kent Brantly 'Seems to Be Improved': CDC Head— Erin McClam
First published August 4th 2014, 12:21 pm
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News